萎缩性胃炎 中国就医指南

Atrophic gastritis is a chronic inflammatory condition of the gastric mucosa characterized by progressive loss of gastric glandular cells, replacement with intestinal-type epithelium (intestinal metaplasia) and fibrous tissue, and consequent reduction in gastric acid and enzyme secretion. It represents an advanced stage of chronic gastritis, often developing over years or decades. Pathogenesis is multifactorial: the most common cause is persistent Helicobacter pylori infection, which triggers chronic immune-mediated inflammation leading to parietal and chief cell atrophy. Autoimmune atrophic gastritis—less common but clinically significant—involves autoantibodies against gastric parietal cells and intrinsic factor, resulting in achlorhydria, vitamin B12 deficiency, and increased risk of pernicious anemia and gastric neuroendocrine tumors. Other contributors include long-term use of proton pump inhibitors (though causality remains debated), bile reflux, smoking, excessive alcohol consumption, and genetic predisposition (e.g., polymorphisms in IL-1β and TNF-α genes). Epidemiologically, atrophic gastritis affects approximately 10–20% of adults globally, with prevalence rising sharply with age—reaching 30–50% in individuals over 60 years. Geographic variation is notable: higher rates are observed in East Asia (especially Japan and China), Eastern Europe, and Latin America, correlating with H. pylori endemicity and dietary factors such as high salt intake and low fruit/vegetable consumption. Risk factors include H. pylori seropositivity (odds ratio >5), autoimmune disorders (e.g., Hashimoto’s thyroiditis, type 1 diabetes), family history of gastric cancer, smoking (2–3× increased risk), and prolonged hypochlorhydria. Clinically, many patients remain asymptomatic for years; when symptoms occur, they are often nonspecific—early satiety, postprandial fullness, epigastric discomfort, mild nausea, or iron-deficiency anemia due to impaired iron absorption. Vitamin B12 deficiency may manifest as fatigue, glossitis, peripheral neuropathy, or cognitive changes. Importantly, atrophic gastritis is a precancerous condition: it confers a 4–6× increased relative risk of gastric adenocarcinoma, particularly when accompanied by intestinal metaplasia and dysplasia. Surveillance endoscopy with targeted biopsies is recommended for high-risk patients. Quality of life impact is frequently underestimated: chronic dyspeptic symptoms reduce daily functioning and nutritional status; B12 deficiency impairs energy metabolism and neurological health; anxiety around cancer risk contributes to psychological distress; and dietary restrictions (e.g., avoidance of spicy or acidic foods) may limit social eating and cultural participation. Early diagnosis via upper endoscopy with histopathological assessment—and timely management of underlying causes—is critical to mitigate complications and preserve gastric function.

# 萎缩性胃炎治疗方案与费用明细（消化内科）

一、非手术/保守治疗方案

适用人群：轻中度萎缩伴肠化生、无高级别上皮内瘤变者；幽门螺杆菌阳性者优先根除。

• •药物治疗（含4周标准根除+3个月黏膜保护）：

- 优选档（进口PPI+高敏抗生素）：3,800–6,200元（含病理免疫组化600元、血清胃功能四项400元）

• •营养干预与随访：维生素B12补充+年度胃镜+病理活检，年均1,500–2,800元

二、内镜下微创干预方案

适用条件：伴低级别上皮内瘤变（LGIN）或局灶高级别病变（HGIN）且符合内镜切除指征者。

• •ESD（内镜黏膜下剥离术）：

- 多灶/≥2cm：38,000–52,000元

三、特殊复杂情况处理

• •广泛HGIN或早期胃癌转化：转外科行腹腔镜远端胃切除术（78,000–115,000元，含基因检测3,500元）
• •自身免疫性萎缩性胃炎伴恶性贫血：终身B12肌注+每半年铁蛋白/同型半胱氨酸监测，年均2,600–4,100元

方案快速选择指南

✅ 预算＜3,000元/年：首选国产四联根除+规律随访 ✅ 发现LGIN/HGIN：立即ESD（医保报销后自付约8,000–25,000元） ✅ 反复出血/重度贫血/进展性萎缩：启动多学科会诊，评估外科干预必要性